CCA
ICU icon

Cruiser Capital Advisors’s SeaStar Medical ICU Stock Holding History

Cruiser Capital Advisors’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-130
Closed -$326K – 81
2021
Q3 		$326K Buy
+130
New +$322K 0.27% 42

Other funds holding ICU

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Cruiser Capital Advisors's ICU Position: Q4 2021 in Review

Cruiser Capital Advisors sold out of SeaStar Medical (ICU) in Q4 2021, closing a stake of 130 shares — an estimated $326K sold.

Cruiser Capital Advisors first reported a position in ICU in Q3 2021 and held it in 1 quarter. The position peaked at $326K in Q3 2021. 44 funds tracked by Wall St. Rank hold ICU as of Q4 2021.

  • Cruiser Capital Advisors reported no remaining SeaStar Medical position as of Q4 2021 after selling out during the quarter.
  • Cruiser Capital Advisors sold 130 SeaStar Medical shares in Q4 2021, an estimated $326K.
  • Cruiser Capital Advisors first reported a position in SeaStar Medical in Q3 2021 and held it in 1 quarter.
  • Cruiser Capital Advisors's SeaStar Medical position peaked at $326K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2021.

Based on Cruiser Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.